Aspen says it is on track to produce Johnson & Johnson’s Covid-19 vaccine at its SA facility.

Business Day TV’s Alishia Seckam spoke to CEO Stephen Saad (https://youtu.be/q7rOs7tIXvk) about what this means for the group...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.